Add like
Add dislike
Add to saved papers

In vitro and in vivo characteristics of biogenic high surface silica nanoparticles in A549 lung cancer cell lines and Danio rerio model systems for inorganic biomaterials development.

Silica based organic-inorganic hybrids are turned over the most necessitate biomaterial due to their exotic biomedical properties. Colloidal silica nanoparticles (SNPs) of high surface area are synthesized from the bamboo wastes (leave biomass) as a viable and promising alternative to synthetic silica sol through alkaline extraction process. Physico-chemical properties of the prepared silica powders are examined employing extensive characterization tools. The characteristic results of the silica sol demonstrate amorphous particles (average size: 25 nm) with relatively high surface area (428 m2  g-1 ) and spherical morphology. The teratogenicity of the surface and size dependant SNPs is evaluated using an alternative animal model, zebrafish (Danio rerio) in comparison with micron sized particles. LDH based cytotoxicity assay reveals non-significant cell damage in all the tested silica particles. Less mortality, uptake and dysfunctionalities of the organs during the developmental stages of zebrafish treated with bulk and nanoparticles confirm their biocompatibility. The least DNA strand breakage during genotoxic assay and teratogenic parameters are found to exhibit desirable bioactivity of SNPs for clinical applications even at higher concentrations. For the first time, bamboo derived silica sol induced genotoxicity is assessed at molecular level to understand the interaction mechanism with the fish genome.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app